SMPD1 and depressive symptom measurement: To our knowledge, this is the first study to show a correlation between S-ASM activities at study inclusion and the prospective course of depression—high enzyme activities were related to both lower depression scores at follow-up (approximately 3 weeks later, for BDI-II) and a stronger improvement in all three depression scales including self-report and clinician assessment.